Shanmuga Hospital IPO: Things Smart Investors Need to Know

    Shanmuga Hospital Limited, incorporated in 2020, is a well-established multispecialty hospital catering to the growing healthcare needs of Salem, Tamil Nadu, and surrounding regions. With a robust infrastructure spanning 45,311 square feet across two blocks and three floors, the hospital is equipped with cutting-edge medical technology and a 151-bed capacity, ensuring comprehensive patient care. Accredited by NABH and NABL, Shanmuga Hospital upholds the highest standards in healthcare services, offering a range of treatments, from preventive care to advanced surgical procedures. Its commitment to excellence has positioned it as a trusted healthcare provider in the region.

    As the hospital moves towards an IPO, investors should note its strong operational foundation and focus on quality-driven medical services. The hospital’s integrated OPD and IPD facilities, along with a dedicated team of healthcare professionals, reinforce its potential for long-term growth. With the healthcare industry expanding rapidly, Shanmuga Hospital’s IPO presents a promising opportunity for investors looking to capitalise on the rising demand for quality medical care.

    For more details, visit the Shanmuga Hospital IPO page.

    Shanmuga Hospital IPO Details and Objectives

    Details

    Information

    IPO Date

    February 13, 2025 to February 17, 2025

    Issue Size

    38,18,000 shares

    (aggregating up to ₹20.62 Cr)

    Price Band

    ₹54 per share

    Lot Size

    2000 shares

    Listing At

    BSE SME

    Market Maker

    Black Fox Financial Private Limited

    Purpose of the IPO

    • Investment in Medical Equipment to enhance healthcare services.

    • General Corporate Expenses for operational growth and sustainability.

    Timeline of Shanmuga Hospital IPO

    Event

    Date

    IPO Open Date

    Thursday, February 13, 2025

    IPO Close Date

    Monday, February 17, 2025

    Basis of Allotment

    Tuesday, February 18, 2025

    Initiation of Refunds

    Wednesday, February 19, 2025

    Credit of Shares to Demat

    Wednesday, February 19, 2025

    Listing Date

    Thursday, February 20, 2025

    Cut-off time for UPI mandate confirmation

    5 PM on February 17, 2025

    Pricing & Lot Size of Shanmuga Hospital IPO

    Price Band for the IPO

    • ₹54 per share

    Minimum Lot Size and Application Details

    Application

    Lots

    Shares

    Amount

    Retail (Min)

    1

    2000

    ₹1,08,000

    Retail (Max)

    1

    2000

    ₹1,08,000

    HNI (Min)

    2

    4,000

    ₹2,16,000

    How to Apply for the Shanmuga Hospital IPO?

    Online Application Process

    • Log in to Your Trading Account
      Access your trading account through your broker’s platform.

    • Navigate to the IPO Section
      Go to the IPO section to view active IPO listings.

    • Select Shanmuga Hospital IPO
      Find "Shanmuga Hospital IPO" and click on the ‘Apply’ button.

    • Enter Application Details
      Specify the number of lots (minimum lot size: 2000 shares) and the bid price within the range of ₹54 per share.

    • Provide Your UPI ID
      Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.

    • Review and Submit
      Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on February 17, 2025, to complete your application process.

    Financial Health and Performance

    Key Financial Metrics

    • Total Assets: Grew from ₹10.65 crore in FY22 to ₹36.53 crore as of September 2024.

    • Revenue: Reached ₹24.83 crore in FY24.

    • Profit After Tax (PAT): Stood at ₹2.39 crore for September 2024.

    • Net Worth: Increased from ₹7.06 crore in FY22 to ₹19.53 crore as of September 2024.

    • Reserves and Surplus: Recorded at ₹9.73 crore (Sept 2024), growing steadily over the years.

    • Total Borrowings: Recorded at ₹9.76 crore in Sept 2024.

    Recent Performance and Growth Prospects

    • Significant Asset Growth, reflecting the hospital’s expanding infrastructure and financial strength.

    • Steady Revenue Increase, demonstrating strong demand for healthcare services.

    • Consistent Profitability, highlighting sustainable financial performance.

    • Strengthened Net Worth, indicating solid financial stability and growth.

    • Growing Reserves and Surplus, ensuring long-term financial resilience.

    • Managed Borrowings, supporting expansion while maintaining financial discipline.

    Investment Risks and Opportunities

    Potential Risks of Investing in the IPO

    • High Dependence on Regional Market: Since Shanmuga Hospital primarily operates in Salem, Tamil Nadu, its growth is heavily reliant on local demand, which may limit expansion opportunities.

    • Competitive Healthcare Sector: The hospital faces competition from both established multispecialty hospitals and emerging healthcare providers, which could impact patient acquisition and revenue growth.

    Opportunities and Growth Potential

    • Expanding Healthcare Demand: With increasing healthcare awareness and rising demand for quality medical services, the hospital is well-positioned to benefit from industry growth.

    • Strategic IPO Utilisation: The investment in advanced medical equipment through IPO proceeds will enhance service offerings, improving patient care and boosting long-term revenue potential.

    Key Performance Indicator (KPI)

    KPI

    Values

    ROE

    30.71%

    ROCE

    35.89%

    Debt/Equity

    0.53

    RoNW

    30.71%

    PAT Margin

    12.13

    Price to Book Value

    3.09

    Shanmuga Hospital IPO Registrar & Lead Managers

    Registrar

    Lead Manager(s)

    Integrated Registry Management Services Private Limited

    Finshore Management Services Limited

    Company Address of Shanmuga Hospital Ltd

    Shanmuga Hospital Limited

    51/24,

    Saradha College Road,

    Salem, 636007

    Phone: +91 427 2706674

    Email: cs@smrft.org

    Website: http://www.shanmugahospital.com/

    Conclusion

    Shanmuga Hospital Limited has established itself as a healthcare provider in Salem, Tamil Nadu, with a focus on comprehensive medical services. The hospital’s infrastructure, medical technology, and accreditation reflect its operational framework. The IPO aims to support investments in medical equipment and general corporate expenses, aligning with its business objectives.

    The healthcare sector continues to evolve, influenced by factors such as demand for medical services, regulatory frameworks, and financial performance. Investors evaluating the IPO may consider aspects like regional market dependence, competition, and potential opportunities in the industry.

    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Shanmuga Hospital IPO.

    Do you have a trading account app or demat account app?

    You can open an account with Bajaj Broking in minutes.

    Download the Bajaj Broking app now from Play Store or App Store.

    Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

    This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

    For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer

    Share this article: 

    Frequently Asked Questions

    Who is the CEO of Shanmuga Hospital Ltd?

    Answer Field

    The CEO of Shanmuga Hospital Ltd. Dr. Prabu Sankar.

    When will the Shanmuga Hospital IPO open for subscription?

    Answer Field

    The Shanmuga Hospital IPO will open for subscription on February 13, 2025, and close on February 17, 2025.

    What is the company’s core business, and how sustainable is its business model in the long term?

    Answer Field

    Shanmuga Hospital Ltd. operates as a multispecialty hospital providing a range of healthcare services, including preventive care and advanced medical treatments. The sustainability of its business model depends on factors such as healthcare demand, regulatory policies, competition, and financial management.

    What is the issue size of the Shanmuga Hospital Ltd IPO?

    Answer Field

    The issue size of the Shanmuga Hospital Ltd. IPO is 38,18,000 shares, aggregating up to ₹20.62 crore.

    What is pre-apply for the Shanmuga Hospital SME IPO?

    Answer Field

    'Pre-apply' allows investors to submit their IPO applications before the official subscription period begins. This feature ensures early participation, with orders being processed when the IPO opens.

    When will I know if my Shanmuga Hospital IPO order is placed?

    Answer Field
    Once an investor submits their application and authorises the UPI mandate, the order is considered placed. Confirmation is usually provided by the broker or trading platform.

    What is the lot size and minimum order quantity of the Shanmuga Hospital IPO?

    Answer Field

    The lot size for the Shanmuga Hospital IPO is 2,000 shares, and the minimum order quantity for retail investors is one lot (2,000 shares).

    What is the allotment date for the Shanmuga Hospital SME IPO?

    Answer Field

    The basis of allotment for the Shanmuga Hospital IPO is expected to be finalised on February 18, 2025.

    Who is the registrar of Shanmuga Hospital Ltd IPO?

    Answer Field

    The registrar for the Shanmuga Hospital Ltd IPO is Integrated Registry Management Services Private Limited.

    Are there any governance issues or red flags in the company’s leadership or board structure?

    Answer Field

    There are no publicly available reports indicating governance issues or red flags in the company’s leadership or board structure. Investors may refer to the company's prospectus and disclosures for further details.

    No Result Found

    Published Date : 11 Feb 2025

    Disclaimer :

    Investments in securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and/or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Our Secure Trading Platforms

    Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    9 lakh+ Users

    icon-with-text

    4.9 App Rating

    icon-with-text

    4 Languages

    icon-with-text

    ₹7,000 Cr+ MTF Book

    icon-with-text
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |